, Vipin M. Vashishtha, an Indian pediatrician who is also a member of the WHO's Vaccine Safety Net program, said he had started to get pediatric COVID-19 cases again, and more children who are sick with XBB.1.16 are experiencing “itchy conjunctivitis with sticky eyes.”on Thursday that experts are seeing the same eye symptoms in young patients who are sick with COVID-19.
“We don't have the context of whether they're seeing that in some of the regions in India. We know their COVID cases are going up, and presumably, these kids are testing positive for COVID, but we don't know if they're testing positive for anything else either,” Chang said. “We are seeing adenovirus circulating, so even if COVID cases go up, unless you're doing testing for both COVID and adenovirus, which most people aren't … it may be difficult [to determine] what's causing your pink eye.”Some doctors say XBB.1.16 may be causing a new symptom among children: conjunctivitis.
It is too early to know how well the COVID-19 vaccines neutralize XBB.1.16. However, some experts believe the shots should remain effective at preventing severe illness and death, even if XBB.1.16 is found to be able to evade antibodies from vaccines. Gandhi explained that this is because, aside from antibodies, there are other parts of the immune system that are activated with vaccination and infection, such as B cells and T cells, which can also offer long-lasting protection against the virus.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
What to know about the XBB. 1.16 'Arcturus' COVID subvariantA new COVID-19 subvariant, XBB. 1.16, has been spreading around the world and gaining more recent traction in the U.S. 🤡 Tell Congress to add into budget. As a must. Out of pocket expenses snd uninsured will suffer. Who cares
Source: axios - 🏆 302. / 63 Read more »
What to know about XBB.1.16, a new Omicron variant on the WHO's radarThere's a new variant of the coronavirus that infectious disease experts and public health officials are keeping a close eye on. XBB.1.16, also known as Arcturus, is an Omicron subvariant that appears to be more transmissible and has fueled a recent surge of COVID-19 cases in India. While the variant is circulating at low levels in the U.S., health officials are closely monitoring it.
Source: WOKVNews - 🏆 247. / 63 Read more »
FDA simplifies COVID vaccine schedules, withdraws authorization for older COVID-19 vaccines targeting virus' original strainThe FDA is authorizing a second omicron-targeted bivalent COVID-19 booster vaccine for people over 65 or who are immunocompromised, the agency announces. no thanks, enough people have dropped dead from this so called vaccine Still pushing propaganda from big pharma. Cause the last vax worked sooooo great right
Source: ABC - 🏆 471. / 51 Read more »
Itchy Eyes? The New ‘Arcturus' COVID Variant, or XBB.1.16, Could Be Behind ItA new COVID variant being monitored by health officials and spreading in multiple countries is bringing with it a new symptom that could be confusing for some this time of year — itchy eyes. Another cover-up: {{they}} have gotten so violent they're punching themselves what about balls itching asking for a friend CityBureaucrat I'm feeling thirsty, could this also be Arcturus at work? 😱
Source: nbcchicago - 🏆 545. / 51 Read more »
Tesla, Netflix earnings and Apple’s India debut top week aheadEarnings from Tesla, Netflix and a slew of regional banks top the week ahead as well as Apple's big push into India.
Source: FoxBusiness - 🏆 458. / 53 Read more »
India's Infosys hits over 2-year low on downbeat revenue outlookInfosys Ltd shares slumped as much as 10% on Monday to their lowest level in over two years after the IT services exporter forecast revenue growth this fiscal would be the slowest in six years and missed profit estimates for the fourth quarter.
Source: Reuters - 🏆 2. / 97 Read more »